Physician profile
Mark L Mayo
NPI 1538144423
$4,321.38
in general payments reported to CMS, 2019-2025
19 companies · $581 in 2025
The $581 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,479 · 2020: $425 · 2021: $438 · 2022: $445 · 2023: $431 · 2024: $524 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,535.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,442.17 | 2019-2025 | Clareon, Argos, Unity |
| Allergan, INC. | $447.76 | 2019-2022 | |
| Carl Zeiss Meditec USA, INC. | $232.02 | 2023 | Clarus, Humphrey Hfa, Iolmaster 700 |
| Sun Pharmaceutical Industries INC. | $215.37 | 2019-2025 | Cequa |
| Rxsight INC | $132.08 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Eyevance Pharmaceuticals LLC | $115.27 | 2019-2021 | |
| Biotissue Holdings INC. | $105.82 | 2019-2024 | |
| Glaukos Corporation | $103.19 | 2021-2025 | Idosetr, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Novartis Pharmaceuticals Corporation | $79.46 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $73.80 | 2019-2021 | |
| Sight Sciences, INC. | $73.64 | 2019-2024 | Omni Surgical System |
| Abbvie INC. | $69.17 | 2022-2024 | |
| Ocular Therapeutix, INC. | $52.22 | 2019-2020 | |
| Optos, INC. | $44.92 | 2019 | |
| Ivantis, INC | $44.56 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $42.98 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $25.45 | 2019 | |
| Mallinckrodt Enterprises LLC | $14.88 | 2019 | |
| New World Medical,INC. | $6.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mayo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.